Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 62.196 USD Market Closed
Market Cap: 4.4B USD

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 149.324 USD with a low forecast of 116.293 USD and a high forecast of 180.542 USD.

Lowest
Price Target
116.293 USD
87% Upside
Average
Price Target
149.324 USD
140% Upside
Highest
Price Target
180.542 USD
190% Upside
Zealand Pharma A/S Competitors:
Price Targets
DVYSR
Devyser Diagnostics AB
58% Upside
NIOX
Niox Group PLC
13% Upside
ZYME
Zymeworks Inc
93% Upside
RYTM
Rhythm Pharmaceuticals Inc
32% Upside
XGN
Exagen Inc
9% Upside
RAPT
Rapt Therapeutics Inc
427% Upside
ALT
Altimmune Inc
305% Upside
RLAY
Relay Therapeutics Inc
492% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

-15%
Past Growth
205%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
149.324 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 149.324 USD with a low forecast of 116.293 USD and a high forecast of 180.542 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
205%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

Back to Top